Scientific Papers

Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study | BMC Medicine


  • Kaplan G, Windsor J. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66.

    Article 
    PubMed 

    Google Scholar
     

  • Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA, Wan Y, Wong J, Boucher K, Pappas L, et al. Family history associates with increased risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2019;17(9):1807-1813.e1801.

    Article 
    PubMed 

    Google Scholar
     

  • Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol. 2014;12(5):756–64.

    Article 
    PubMed 

    Google Scholar
     

  • Shah S, Itzkowitz S. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162(3):715-730.e713.

    Article 
    PubMed 

    Google Scholar
     

  • Farraye F, Melmed G, Lichtenstein G, Kane S. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–58.

    Article 
    PubMed 

    Google Scholar
     

  • Amiot A, Bouguen G, Bonnaud G, Bouhnik Y, Hagege H, Peyrin-Biroulet L. Clinical guidelines for the management of inflammatory bowel disease: update of a French national consensus. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2021;53(1):35–43.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Biancone L, Armuzzi A, Scribano ML, Castiglione F, D’Incà R, Orlando A, Papi C, Daperno M, Vecchi M, Riegler G, et al. Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study. Inflamm Bowel Dis. 2020;26(3):450–9.

    PubMed 

    Google Scholar
     

  • Jussila A, Virta LJ, Pukkala E, Färkkilä MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8(9):1088–96.

    Article 
    PubMed 

    Google Scholar
     

  • Wu S, Xie S, Yuan C, Yang Z, Liu S, Zhang Q, Sun F, Wu J, Zhan S, Zhu S, et al. Inflammatory bowel disease and long-term risk of cancer: a prospective cohort study among half a million adults in UK Biobank. Inflamm Bowel Dis. 2023;29(3):384–95.

    Article 
    PubMed 

    Google Scholar
     

  • Kappelman MD, Farkas DK, Long MD, Erichsen R, Sandler RS, Sørensen HT, Baron JA. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265-273.e261.

    Article 
    PubMed 

    Google Scholar
     

  • Kaplan G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.

    Article 
    PubMed 

    Google Scholar
     

  • Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, Evans DM, Smith GD. Recent developments in Mendelian randomization studies. Current epidemiology reports. 2017;4(4):330–45.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, Jostins L, Rice DL, Gutierrez-Achury J, Ji SG, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256–61.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liang B, Ding H, Huang L, Luo H, Zhu X. GWAS in cancer: progress and challenges. Mol Genet Genomics. 2020;295(3):537–61.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen G, Xie J, Liang T, Wang Y, Liao W, Song L, Zhang X. Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization. Acta Otolaryngol. 2022;142(2):191–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–86.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hecht SS, Hatsukami DK. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22(3):143–55.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet (London, England). 2018;392(10152):1015–35.

  • Malcomson FC, Parra-Soto S, Lu L, Ho F, Celis-Morales C, Sharp L, Mathers JC. Socioeconomic differences in adherence to the World Cancer Research Fund Cancer Prevention Recommendations in the UK Biobank cohort. Lancet (London, England). 2022;400(Suppl 1):S60.

    Article 

    Google Scholar
     

  • Suh S, Kim KW. Diabetes and cancer: cancer should be screened in routine diabetes assessment. Diabetes Metab J. 2019;43(6):733–43.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–64.

    Article 
    PubMed 

    Google Scholar
     

  • Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014;46(7):736–41.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986–90.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017;49(5):680–91.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • O’Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, et al. Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018;9(1):3166.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928–36.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92–4.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Laskar RS, Muller DC, Li P, Machiela MJ, Ye Y, Gaborieau V, Foll M, Hofmann JN, Colli L, Sampson JN, et al. Sex specific associations in genome wide association analysis of renal cell carcinoma. Eur J Hum Genet. 2019;27(10):1589–98.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Köhler A, Chen B, Gemignani F, Elisei R, Romei C, Figlioli G, Cipollini M, Cristaudo A, Bambi F, Hoffmann P, et al. Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab. 2013;98(10):E1674-1681.

    Article 
    PubMed 

    Google Scholar
     

  • Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, Lacko M, Eluf-Neto J, Franceschi S, Lagiou P, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48(12):1544–50.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11(1):597.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Niu W, Gu M. Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity. Tumour Biol. 2016;37(2):1527–9.

    Article 
    PubMed 

    Google Scholar
     

  • Freuer D, Meisinger C. Association between inflammatory bowel disease and Parkinson’s disease: a Mendelian randomization study. NPJ Parkinson’s disease. 2022;8(1):55.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xie J, Huang H, Liu Z, Li Y, Yu C, Xu L, Xu C. The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology. 2023;77(3):949–64.

    Article 
    PubMed 

    Google Scholar
     

  • Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31(29):3805–20.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Murphy AE, Schilder BM, Skene NG. MungeSumstats: a Bioconductor package for the standardization and quality control of many GWAS summary statistics. Bioinformatics. 2021;37(23):4593–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–106.

    Article 
    PubMed 

    Google Scholar
     

  • Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161(4):1118–32.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Peyrin-Biroulet L, Bonnaud G, Bourreille A, Chevaux J, Faure P, Filippi J, Laharie D, Vuitton L, Bulois P, Gonzalez F, et al. Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED). Endoscopy. 2013;45(11):936–43.

    Article 
    PubMed 

    Google Scholar
     

  • Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar G, Ghosh S, Shen B. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. The lancet Gastroenterology & hepatology. 2020;5(6):598–606.

    Article 

    Google Scholar
     

  • Katsanos KH, Roda G, McBride RB, Cohen B, Colombel JF. Increased risk of oral cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14(3):413–20.

    Article 
    PubMed 

    Google Scholar
     

  • Giagkou E, Christodoulou DK, Katsanos KH. Mouth cancer in inflammatory bowel diseases. Oral Dis. 2016;22(4):260–4.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis. 2015;21(2):409–18.

    Article 
    PubMed 

    Google Scholar
     

  • Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011;140(6):1807–16.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(5):935–42.

    Article 
    PubMed 

    Google Scholar
     

  • Wan Q, Zhao R, Xia L, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu XT. Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies. J Cancer Res Clin Oncol. 2021;147(4):1077–87.

    Article 
    PubMed 

    Google Scholar
     

  • Selinger CP. Gastric cancer in patients with inflammatory bowel disease: more than just a random association? Journal of gastrointestinal and liver diseases : JGLD. 2017;26(1):11–2.

    Article 
    PubMed 

    Google Scholar
     

  • Barner-Rasmussen N, Pukkala E, Hadkhale K, Färkkilä M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United European gastroenterology journal. 2021;9(10):1128–35.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Erichsen R, Olén O, Sachs M, Pedersen L, Halfvarson J, Askling J, Ekbom A, Ludvigsson J, Sørensen H. Hepatobiliary cancer risk in patients with inflammatory bowel disease: a Scandinavian population-based cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021;30(5):886–94.

    Article 

    Google Scholar
     

  • Xie Y, Chen X, Deng M, Sun Y, Wang X, Chen J, Yuan C, Hesketh T. Causal linkage between inflammatory bowel disease and primary sclerosing cholangitis: a two-sample mendelian randomization analysis. Front Genet. 2021;12: 649376.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yu J, Refsum E, Helsingen L, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal H, Melum E, Løberg M, et al. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study. United European gastroenterology journal. 2022;10(2):212–24.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hovde Ø, Høivik ML, Henriksen M, Solberg IC, Småstuen MC, Moum BA. Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study. J Crohns Colitis. 2017;11(5):571–7.

    PubMed 

    Google Scholar
     

  • Gong C, Xu R, Zou P, Zhang Y, Wang X. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies. Eur J Cancer Prev. 2022;31(1):54–63.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gutmann H, Hruz P, Zimmermann C, Straumann A, Terracciano L, Hammann F, Lehmann F, Beglinger C, Drewe J. Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion. 2008;78(2–3):154–62.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Piovani D, Hassan C, Repici A, Rimassa L, Carlo-Stella C, Nikolopoulos GK, Riboli E, Bonovas S. Risk of cancer in inflammatory bowel diseases: umbrella review and reanalysis of meta-analyses. Gastroenterology. 2022;163(3):671–84.

    Article 
    PubMed 

    Google Scholar
     

  • Sun BB, Kurki MI, Foley CN, Mechakra A, Chen CY, Marshall E, Wilk JB, Chahine M, Chevalier P, Christé G, et al. Genetic associations of protein-coding variants in human disease. Nature. 2022;603(7899):95–102.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet. 1999;8(10):1913–23.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang F, Zhou Y, Chen H, Jiang H, Zhou F, Lv B, Xu M. Curcumin alleviates DSS-induced anxiety-like behaviors via the microbial-brain-gut axis. Oxid Med Cell Longev. 2022;2022:6244757.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The brain-gut axis: psychological functioning and inflammatory bowel diseases. J Clin Med. 2021;10(3):377.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Khrom M, Li D, Naito T, Lee HS, Botwin GJ, Potdar AA, Boucher G, Yang S, Mengesha E, Dube S, et al. Sex-dimorphic analyses identify novel and sex-specific genetic associations in inflammatory bowel disease. Inflamm Bowel Dis. 2023;29(10):1622–32.

    Article 
    PubMed 

    Google Scholar
     



  • Source link